Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05384158 · ClinicalTrials.gov registry record · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
A NA study of Neurobehavioral Components of Reward and Loss Valuation, sponsored by Virginia Polytechnic Institute and State University.
- Recruiting
- Registry status
- NA
- Development phase
- 252
- Enrollment target
- 1
- Study location
NCT05384158: Recruiting NA study of Neurobehavioral Components of Reward and Loss Valuation, sponsored by Virginia Polytechnic Institute and State University.
NCT05384158 is a NA study of Neurobehavioral Components of Reward and Loss Valuation that is actively recruiting participants, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 252 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05384158, a NA study of Neurobehavioral Components of Reward and Loss Valuation, is actively recruiting participants, sponsored by Virginia Polytechnic Institute and State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines how people respond to rewards and losses, and the extent to which these responses are linked or distinct among people experiencing depressed mood, anhedonia, and/or anxiety.
Primary Outcome
change in proportion correct on 'N-arm bandit reinforcement learning task' from study entrance to study exit
Conditions Studied
Interventions
- BEHAVIORAL cognitive behavioral therapy
- BEHAVIORAL valuation with instruction
- BEHAVIORAL valuation without instruction
Study Locations (1)
Virginia
- Fralin Biomedical Research Institute at Virginia Tech Carilion - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT05384158 shows while recruiting
NCT05384158 is an interventional study that assigns participants to a tested intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Neurobehavioral Components of Reward and Loss Valuation appearing as the primary indexed condition, and to 3 interventions - of which cognitive behavioral therapy is the first listed.
NCT05384158 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05384158 about?
NCT05384158 is a clinical study titled "Valuation in Depressed Mood, Anhedonia, and Anxiety". This study examines how people respond to rewards and losses, and the extent to which these responses are linked or distinct among people experiencing depressed mood, anhedonia, and/or anxiety.
What is the current status of trial NCT05384158?
This trial is currently recruiting. It is a NA study. The enrollment target is 252 participants. The study started on 2021-08-01. Estimated completion is 2026-07.
What conditions does trial NCT05384158 study?
This clinical trial studies the following conditions: Neurobehavioral Components of Reward and Loss Valuation.
What interventions are being tested in trial NCT05384158?
The interventions under investigation include: cognitive behavioral therapy (BEHAVIORAL), valuation with instruction (BEHAVIORAL), valuation without instruction (BEHAVIORAL).
Who is sponsoring clinical trial NCT05384158?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05384158 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05384158's enrollment target sits among peer trials
252 407th of 2000 higher than 1,591 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05465044 · 252 participants · NA
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI